ORIC   $11.28  1.08% Market Closed After Close 11.25 -0.27%

Oric Pharmaceuticals Inc
Total Cash 286.41M
totalCashPerShare 4.06
EBITDA -124.06M
Total Debt 9.74M
quickRatio 14.658
currentRatio 15.077
Total Revenue
debtToEquity 3.22
Revenue/Share
ROA -0.25195998
ROE -0.38789
grossProfits
freeCashflow -59.14M
operatingCashflow -99.73M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 421.00M
forwardPE -4.864734
floatShares 42.72M
sharesOutstanding 70.54M
sharesShort 12.67M
sharesShortPriorMonth 11.92M
dateShortInterest
sharesPercentSharesOut 0.18%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.97%
Short Ratio help_outline 28.20%
shortPercentOfFloat 0.18%
impliedSharesOutstanding
bookValue 4.469
Price To Book help_outline 2.25
earningsQuarterlyGrowth
netIncomeToCommon -110.78M
trailingEps -1.76%
forwardEps -2.07%
enterpriseToEbitda -3.39
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.49 3Q 2024
institutionsCount 164
lastUpdated Sept. 16, 2024, 7:53 p.m.